GuiZhou SanLi Pharmaceutical Co., Ltd.SSE: 603439

Announcement on Expected Decrease in Semi-annual Performance for 2026

Jul 15, 2026 · Issued by GuiZhou SanLi Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 15, 2026 · 2 pages · Chinese

On 6ix: 6ix.com/news/guizhou-sanli-pharmaceutical-co-ltdannouncement-on-expected-decrease-in-semi-annual-performance-for-2026

Release

Announcement on Expected Decrease in Semi-annual Performance for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

GuiZhou SanLi Pharmaceutical Co., Ltd. on 6ix

Earlier from GuiZhou SanLi Pharmaceutical

Announcement on Pledging Partial Shares of Person Acting in Concert of Controlling ShareholderJul 3
Announcement on Implementation of Dividend Distribution for 2025Jun 24
Announcement on Progress in Drug Marketing Authorization TransferJun 9
Announcement on Resolutions of the 24th Meeting of the 4th Board of DirectorsMay 26
Announcement on Resolutions of the 2025 Annual General MeetingMay 21

Later from GuiZhou SanLi Pharmaceutical

Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive PlanJul 22
Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual ReportJul 24
Semi-annual Report for 2026Aug 28
Announcement on Abnormal Fluctuations in Stock TradingSep 15
(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Pledge of Certain Shares Held by Controlling ShareholderOct 17

All GuiZhou SanLi Pharmaceutical news releases

Follow GuiZhou SanLi Pharmaceutical into a list and get an email when it puts out news.

Follow GuiZhou SanLi Pharmaceutical